Sponsor: PrognomiQ, Inc
Sponsor Study ID: P-030101
Study Title: Advanced Precision Observational Lung Living Outcomes: Lung Cancer Screening Study
CTO #: 103802
NCT Number:
Phase: N/A
Protocol Type: Diagnostic
Age Group: Adults
Disease Sites: Lung
Study Objectives: The objective of this study is to develop new and/or validate a panel of blood-based biomarkers and candidate classifiers developed by PrognomiQ for lung cancer detection in patients undergoing lung cancer screening.